Literature DB >> 18825473

A case of Takayasu arteritis complicated by Castleman's disease.

Saeko Takahashi1, Ikuo Kamiyama, Akitoshi Ishizaka.   

Abstract

We describe the first case of Takayasu Arteritis (TA) complicated by multicentric hyaline-vascular type of Castleman's disease (CD) which was diagnosed by the biopsy of mediastinal lymphnode 23 years after the diagnosis of TA. CD is classified as a lymphoid disorder of immune regulation characterized by a systemic, unregulated B cell proliferation, and there are some reports about the coincidence of CD and autoimmune diseases. This case has allowed us to gain some insight into a possible relation between the two disorders.

Entities:  

Mesh：

Year:  2008        PMID： 18825473     DOI： 10.1007/s10067-008-1014-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  10 in total

1.  Systemic lupus erythematosus and Castleman's disease.

Authors:  S Suwannaroj; S L Elkins; R W McMurray
Journal:  J Rheumatol       Date:  1999-06       Impact factor: 4.666

2.  Unicentric Castleman's lymphadenopathy presenting with Behçet's syndrome: a case report.

Authors:  M L Pacor; P Peroli; S Givanni; A Ambrosetti; D Biasi; L M Bambara; A Frigo; G Urbani; C Lunardi
Journal:  Haematologica       Date:  1990 Sep-Oct       Impact factor: 9.941

Review 3.  Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans.

Authors:  T Chorzelski; T Hashimoto; B Maciejewska; M Amagai; G J Anhalt; S Jablonska
Journal:  J Am Acad Dermatol       Date:  1999-09       Impact factor: 11.527

4.  Multicentric Castleman's disease associated with rheumatoid arthritis: a possible role of hepatitis B antigen.

Authors:  E Ben-Chetrit; D Flusser; E Okon; Z Ackerman; A Rubinow
Journal:  Ann Rheum Dis       Date:  1989-04       Impact factor: 19.103

5.  Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions?

Authors:  M Noris; E Daina; S Gamba; S Bonazzola; G Remuzzi
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

6.  Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.

Authors:  S J Brandt; D M Bodine; C E Dunbar; A W Nienhuis
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

7.  Giant lymph node hyperplasia associated with thrombotic thrombocytopenic purpura.

Authors:  W D Couch
Journal:  Am J Clin Pathol       Date:  1980-09       Impact factor: 2.493

8.  Mixed connective tissue disease associated with multicentric Castleman's disease.

Authors:  T Nanki; J Tomiyama; S Arai
Journal:  Scand J Rheumatol       Date:  1994       Impact factor: 3.641

9.  Renal thrombotic microangiopathy associated with multicentric Castleman's disease. Report of two cases.

Authors:  G Lajoie; S Kumar; K W Min; F G Silva
Journal:  Am J Surg Pathol       Date:  1995-09       Impact factor: 6.394

10.  Durable remission of HIV-negative, Kaposi's sarcoma herpes virus-associated multicentric Castleman disease in patient with rheumatoid arthritis treated with methotrexate.

Authors:  Samuel A Jacobs; Nicholas Vidnovic; Hitendra Patel; Lorinda A Soma; Yuan Chang; Noah Bass; Steven H Swerdlow
Journal:  Clin Rheumatol       Date:  2006-07-06       Impact factor: 3.650
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.